20.08.2014
Report on cost-benefit ratings of registered drugs presented in Berlin

Report on cost-benefit ratings of registered drugs presented in Berlin

The Centre for Social Policy Research (ZeS) at the University of Bremen continues the cost-benefit assessment of drugs with existing admission to the pharmaceuticals market.

The today presented report on cost-benefit ratings of registered drugs assesses the additional patient-oriented value and cost-effectiveness of selected pharmaceuticals, the way it was originally intended in AMNOG. The authors Daniela Boeschen, Roland Windt and Gerd Glaeske examined prescriptions of selected patented pharmaceuticals, based on routine data of the TK health insurance fund. They compared and assessed the analyzed drugs in addition according to the available evidence. Read more ...

14.08.2014
New volume in ZeS book series

New volume in ZeS book series

Dissertation of Magnus Brosig published in ZeS book series.

The dissertation of Magnus Brosig (accepted in December 2013) has been published as part of the ZeS book series on August 14th. Drawing on the public and scientific debate on a possible return of widespread old-age poverty, it analyses pertinent ideas of relevant actors and uses them to sketch prospects for reform of the German pension system. Read more ...

30.06.2014
Carina Schmitt appointed to the Junge Akademie

Carina Schmitt appointed to the Junge Akademie

Carina Schmitt has been coopted as one of ten new members to the Junge Akademie.

The selection committee of the Berlin-Brandenburg Academy of Sciences and Humanities and the German National Academy of Sciences Leopoldina decided to coopt Carina Schmitt to the Junge Akademie in march this year. Members have different backgrounds ranging from Astrophysics via Law and Political Science to Philosophy of Science and are elected for five years. Read more ...